2657 (2657) Fair Value & Analysis

Consumer Defensive · Market cap HK$5.3B

2 2657 2657 · HK

PriceHK$37.12

Fair ValueHK$76.89

Upside+107.1%

Quality46/100

Watch 2657 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$57.67 – HK$136.97

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −4.8% over the past month.

Price vs Fair Value (6 months)

6‑month range HK$28.60 – HK$91.54 · fair‑value band HK$57.67 – HK$136.97 · the HK$37.12 price screens below the HK$76.89 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2657 (2657) currently trades at HK$37.12, while our model-based Fair Value estimate is HK$76.89 — implying the stock looks roughly 107.1% undervalued today. We read business quality at 46/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 2657 generated revenue of HK$2.4B at a net margin of 14.7%. Revenue grew 105.8% year over year. It earns a return on equity of 29.5%. The stock trades on a trailing P/E of 11.2. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$2.4B

Revenue growth (YoY) +106%

Net margin 14.7%

Return on equity 29.5%

Free cash flow HK$333M FY2025

P/E ratio 11.2

More key figures

Operating margin 14.1%

Dividend yield 2.8%

EPS growth (YoY) +78.0%

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

2657 reported revenue of HK$2.4B in FY2025 versus HK$691M in FY2022, a compound +52.5%/yr. Reported net income was HK$360M in FY2025.

Revenue +52.5%/yr

FY22 HK$691M

FY23 HK$805M

FY24 HK$1.2B

FY25 HK$2.4B

Net income

FY22 −HK$5.9M

FY23 HK$84.5M

FY24 HK$187M

FY25 HK$360M

Is 2657 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	108.66 MXN	-96%
The Procter & Gamble Company PGCO34	R$54.71	R$7.69	-86%
L'Oréal S.A LRLCF	$445.77	$275.67	-38%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.16	€55.96	-29%
Hindustan Unilever Limited HINDUNILVR	₹2,185	₹1,000	-54%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2657 (2657) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$76.89 versus a price of HK$37.12 — about +107% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 2657?

Our model-based fair value for 2657 is HK$76.89 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$37.12.

What is the quality score of 2657?

2657 has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2657 (2657)?

2657 reported trailing-twelve-month revenue of about HK$2.4B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2657?

The net profit margin of 2657 is about 14.7%, meaning it keeps roughly 14.7% of revenue as net income. Based on the latest reported figures.

Does 2657 pay a dividend?

2657 currently shows a dividend yield of about 2.82% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.